home.social

#weightlossdrugs — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #weightlossdrugs, aggregated by home.social.

  1. Medicare Initiates Temporary Program for GLP-1 Weight Loss Drugs

    Medicare's new GLP-1 Bridge program will offer eligible seniors weight loss drugs for $50/month starting July 1, 2026. Find out who qualifies.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth

    newsletter.tf/medicare-weight-

  2. Medicare Initiates Temporary Program for GLP-1 Weight Loss Drugs

    Medicare's new GLP-1 Bridge program will offer eligible seniors weight loss drugs for $50/month starting July 1, 2026. Find out who qualifies.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth

    newsletter.tf/medicare-weight-

  3. Medicare Initiates Temporary Program for GLP-1 Weight Loss Drugs

    Medicare's new GLP-1 Bridge program will offer eligible seniors weight loss drugs for $50/month starting July 1, 2026. Find out who qualifies.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth

    newsletter.tf/medicare-weight-

  4. Medicare Initiates Temporary Program for GLP-1 Weight Loss Drugs

    Medicare's new GLP-1 Bridge program will offer eligible seniors weight loss drugs for $50/month starting July 1, 2026. Find out who qualifies.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth

    newsletter.tf/medicare-weight-

  5. Starting July 1, 2026, Medicare will offer a temporary program for weight loss drugs. Eligible beneficiaries could pay around $50 per month, a significant change from previous coverage limits.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth
    newsletter.tf/medicare-weight-

  6. Starting July 1, 2026, Medicare will offer a temporary program for weight loss drugs. Eligible beneficiaries could pay around $50 per month, a significant change from previous coverage limits.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth
    newsletter.tf/medicare-weight-

  7. Starting July 1, 2026, Medicare will offer a temporary program for weight loss drugs. Eligible beneficiaries could pay around $50 per month, a significant change from previous coverage limits.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth
    newsletter.tf/medicare-weight-

  8. Starting July 1, 2026, Medicare will offer a temporary program for weight loss drugs. Eligible beneficiaries could pay around $50 per month, a significant change from previous coverage limits.

    #Medicare #WeightLossDrugs #GLP1 #HealthcareCosts #SeniorHealth
    newsletter.tf/medicare-weight-

  9. Novo Nordisk India Sees Sales Surge Amidst Price Wars

    Novo Nordisk India sales grew 40% as generic drugs entered the market. Find out how branded drugs like Ozempic are still selling well.

    #NovoNordiskIndia, #OzempicSales, #WeightLossDrugs, #PharmaIndia, #Semaglutide

    newsletter.tf/novo-nordisk-ind

  10. Obese Seek Weight Loss Drugs Amidst Shifting Insurance Tides

    Insurance like Medicare and Medicaid are limiting coverage for weight loss drugs (Wegovy, Ozempic). Many obese patients now face higher costs or denied access.

    #WeightLossDrugs, #Ozempic, #Wegovy, #InsuranceCoverage, #ObesityTreatment

    newsletter.tf/weight-loss-drug

  11. Insurance coverage for popular weight loss drugs like Wegovy and Ozempic is becoming harder to get. This is different from last year when more people could access them for obesity.

    #WeightLossDrugs, #Ozempic, #Wegovy, #InsuranceCoverage, #ObesityTreatment
    newsletter.tf/weight-loss-drug

  12. The rise of weight-loss drugs is in danger of turning a public-health issue (the 'obesity crisis') into a consumer choice issue and is a dangerous shift (not least as the drugs have unwelcome side-effects).

    We should be focussed on people's health & well-being, and while that may involve some weight loss, a focus on attaining some ultra thin emerging norm is dangerous & driven not by health concerns but by pharmaceutical profits.

    #health #WeightLossDrugs #politics

    theguardian.com/science/2026/m